Phase I/II proof-of-concept trial of calcipotriol, formulated with AKVANO, for the topical treatment of patients with psoriasis vulgaris.
Phase of Trial: Phase I/II
Latest Information Update: 30 Aug 2013
Price : $35 *
At a glance
- Drugs Calcipotriol (Primary)
- Indications Psoriasis
- Focus Therapeutic Use
- 30 Aug 2013 New trial record
- 27 Aug 2013 Results have been reported in a Karolinska Development AB media release. Infiltrate thickness reduction was achieved and the drug was well tolerated.
- 27 Aug 2013 Primary endpoint 'Clinical-response-rate' (infiltrate thickness reduction) has been met according to a Karolinska Development AB media release.